ARTV
Artiva Biotherapeutics, Inc.
6.80$
-2.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | |
| 1,493.5% | 322.0% | 49.0% | 474.6% | 4,444.6% | – | – | – | – | – | – | – | – | – | – | |
| 394.9% | 116.1% | 10.4% | 134.8% | 1,429.1% | – | – | – | – | – | – | – | – | – | – | |
| 1,888.5% | 438.1% | 59.4% | 609.4% | 5,873.7% | – | – | – | – | – | – | – | – | – | – | |
| -1,788.5% | -338.1% | 40.6% | -509.4% | -5,773.7% | – | – | – | – | – | – | – | – | – | – | |
| – | 14.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1,690.3% | -322.7% | 42.3% | -507.5% | -5,562.9% | – | – | – | – | – | – | – | – | – | – | |
| -103.5% | 14.6% | – | 3.1% | -152.2% | – | – | – | – | – | – | – | – | – | – | |
| -1,690.3% | -322.7% | 42.3% | -510.6% | -5,562.9% | – | – | – | – | – | – | – | – | – | – | |
| -1,631.9% | -292.7% | 44.4% | -482.2% | -5,329.1% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.